WorldChinaJapanIndiaSouth KoreaIndonesiaTaiwanThailandU.S.East AsiaChinaHong KongMacaoTaiwanMongoliaJapanSouth KoreaNorth KoreaSoutheast AsiaIndonesiaThailandMalaysiaSingaporePhilippinesVietnamMyanmarCambodiaLaosBruneiEast TimorSouth AsiaIndiaPakistanAfghanistanBangladeshSri LankaNepalBhutanMaldivesCentral AsiaKazakhstanUzbekistanTurkmenistanTajikistanKyrgyzstanOceaniaAustraliaNew ZealandPapua New GuineaPacific IslandsRest of the WorldMiddle EastRussia & CaucasusNorth AmericaLatin AmericaEuropeAfricaTrendingTrump-Xi SummitIran tensionsInflationTrump administrationArtificial intelligenceElectric vehiclesSupply ChainTaiwan tensionsBank of JapanImmigrationESGExplainerBusinessBusinessSemiconductorsAutomobilesEnergyTransportationRetailTravel & LeisureMedia & EntertainmentFood & BeverageFinanceElectronicsStartupsBusiness dealsMarketsMarketsEquitiesCurrenciesBondsCommoditiesPropertyIPOWealth ManagementTechTech#techAsiaChina techStartupsCryptocurrenciesDealStreetAsiaPoliticsPoliticsChinaJapanIndiaSouth KoreaIndonesiaTaiwanThailandU.S.East AsiaChinaHong KongMacaoTaiwanMongoliaJapanSouth KoreaNorth KoreaSoutheast AsiaIndonesiaThailandMalaysiaSingaporePhilippinesVietnamMyanmarCambodiaLaosBruneiEast TimorSouth AsiaIndiaPakistanAfghanistanBangladeshSri LankaNepalBhutanMaldivesCentral AsiaKazakhstanUzbekistanTurkmenistanTajikistanKyrgyzstanOceaniaAustraliaNew ZealandPapua New GuineaPacific IslandsRest of the WorldMiddle EastRussia & CaucasusNorth AmericaLatin AmericaEuropeAfricaEconomyEconomyChinaJapanIndiaSouth KoreaIndonesiaTaiwanThailandU.S.East AsiaChinaHong KongMacaoTaiwanMongoliaJapanSouth KoreaNorth KoreaSoutheast AsiaIndonesiaThailandMalaysiaSingaporePhilippinesVietnamMyanmarCambodiaLaosBruneiEast TimorSouth AsiaIndiaPakistanAfghanistanBangladeshSri LankaNepalBhutanMaldivesCentral AsiaKazakhstanUzbekistanTurkmenistanTajikistanKyrgyzstanOceaniaAustraliaNew ZealandPapua New GuineaPacific IslandsRest of the WorldMiddle EastRussia & CaucasusNorth AmericaLatin AmericaEuropeAfricaFeaturesTrading AsiaASEAN MoneyTech AsiaBusiness AsiaChina Up ClosePolicy AsiaBig in AsiaDatawatchInfographicsOpinionOpinionEditor-in-Chief's PicksThe Nikkei ViewLife & ArtsLife & ArtsLifeArtsMy Personal HistoryTea LeavesEat & DrinkDestinationsBooksObituariesWatch & ListenPodcastsVideoPhotosArtificial intelligenceCompany's work aims to find enough participants for clinical trials for overlooked illnessesJMDC employees discuss the use of medical data. (Photo by Yuta Maeda)YUTA MAEDAMay 14, 2026 22:11 JSTTOKYO -- A healthcare data subsidiary of Japanese medical device maker Omron is unleashing artificial intelligence on a huge trove of patient data in hopes of finding rare-disease clusters large enough to help unlock new treatments.Read NextLatest on Artificial intelligenceSponsored ContentAbout Sponsored ContentThis content was commissioned by Nikkei's Global Business Bureau.